Outcome of kidney transplantation in African-Americans using tacrolimus.
作者信息
Scantlebury V P, Shapiro R, Irish W, Jordan M L, Vivas C, Gritsch H A, Fung J J, McCauley J, Simmons R L, Starzl T E
机构信息
Thomas E. Starzl Transplantation Institute, Departments of Surgery and Urology, University of Pittsburgh Medical Center, PA 15213, USA.
出版信息
Transplant Proc. 1997 Dec;29(8):3731-2. doi: 10.1016/s0041-1345(97)01090-7.
Abstract
摘要
相似文献
1
Outcome of kidney transplantation in African-Americans using tacrolimus.使用他克莫司的非裔美国人肾移植结果。
Transplant Proc. 1997 Dec;29(8):3731-2. doi: 10.1016/s0041-1345(97)01090-7.
2
Tacrolimus-based immunosuppression in pediatric renal transplantation.小儿肾移植中基于他克莫司的免疫抑制治疗
Transplant Proc. 1999 Nov;31(7A):29S-30S. doi: 10.1016/s0041-1345(99)00790-3.
3
Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil.接受者种族、使用霉酚酸酯时钙调神经磷酸酶抑制剂类型与急性排斥反应发生率的关系。
Transplant Proc. 2002 Dec;34(8):3119-21. doi: 10.1016/s0041-1345(02)03662-x.
4
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.
Transplant Proc. 2002 Aug;34(5):1617-8. doi: 10.1016/s0041-1345(02)03045-2.
5
Outcome of tacrolimus-treated renal transplantation from elderly donors.他克莫司治疗老年供体肾移植的结果。
Transplant Proc. 2000 Nov;32(7):1723-5. doi: 10.1016/s0041-1345(00)01399-3.
6
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group.种族和免疫抑制对肾移植的影响：一项美国多中心随机试验的三年生存结果。FK506肾移植研究组
Transplant Proc. 1998 Jun;30(4):1355-8. doi: 10.1016/s0041-1345(98)00274-7.
7
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience.肾移植中他克莫司初始及挽救治疗下的糖皮质激素撤减：芝加哥的经验
Transplant Proc. 1999 Nov;31(7A):84S-85S. doi: 10.1016/s0041-1345(99)00803-9.
8
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.尸体肾移植后他克莫司联合霉酚酸酯或硫唑嘌呤与（改良）环孢素口服溶液联合霉酚酸酯的随机试验：2年结果
Transplantation. 2001 Jul 27;72(2):245-50. doi: 10.1097/00007890-200107270-00014.
9
Living unrelated kidney transplantation.活体非亲属肾移植
Transplant Proc. 1997 Nov;29(7):2770-2. doi: 10.1016/s0041-1345(97)00671-4.
10
Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.他克莫司作为尸体肾移植的主要免疫抑制疗法：单中心五年经验
Transplant Proc. 1998 Jun;30(4):1598-9. doi: 10.1016/s0041-1345(98)00366-2.
本文引用的文献
1
An increased incidence of rejection episodes. One of the causes of worse kidney transplantation survival in black recipients.排斥反应发生率增加。这是黑人受者肾移植存活率较低的原因之一。
Arch Surg. 1997 Jan;132(1):35-9; discussion 40. doi: 10.1001/archsurg.1997.01430250037007.
2
Factors affecting renal allograft survival in African Americans.影响非裔美国人肾移植存活率的因素。
Blood Purif. 1996;14(4):327-33. doi: 10.1159/000170281.
3
The impact of quadruple immunosuppression with OKT3 on kidney transplantation in black recipients.OKT3四联免疫抑制对黑人受者肾移植的影响。
Am J Surg. 1996 Jul;172(1):56-60. doi: 10.1016/S0002-9610(96)00059-1.
4
Improving renal transplant outcomes in African Americans with OKT3 induction therapy.采用OKT3诱导疗法改善非裔美国人肾移植的预后。
Transplant Proc. 1993 Aug;25(4):2436-8.
5
Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival.黑人受者的肾移植。HLA配型及影响移植肾长期存活的其他因素。
Transplantation. 1994 Apr 15;57(7):1064-8.
6
Renal transplantation under FK 506 in African-Americans: early experience.非裔美国人在使用FK506情况下的肾移植：早期经验
Transplant Proc. 1993 Aug;25(4):2468-9.
7
The effect of race on access and outcome in transplantation.种族对移植获取及结局的影响。
N Engl J Med. 1991 Jan 31;324(5):302-7. doi: 10.1056/NEJM199101313240505.
8
Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors.尸体肾移植受者存活情况的种族差异。HLA配型和社会经济因素的主导作用。
N Engl J Med. 1992 Sep 17;327(12):840-5. doi: 10.1056/NEJM199209173271203.
Zotero 插件